Skip to main content
Find a Doctor
Services
Locations
Patients & Visitors
Appointments
Billing
Clinical Trials
MyChart
Search all site content
Search site
Locations
Doctors
UVA Health
Appointments
Billing
Clinical Trials
Careers
MyChart
UVA Health
Find a Doctor
Services
Locations
Patients & Visitors
Search
Menu
Search all site content
Search site
Home
Clinical Trial Categories
development
In This Section
Clinical Trials
Clinical Trials
Principal Investigator
Search for ‘
development
’ results: 1-7 of 7
Acute Leukemia
A Phase 3 Randomized Trial for Patients with de novo AML Comparing Standard Therapy Including Gemtuzumab Ozogamicin (GO) to CPX-351 with GO, and the Addition of the FLT3 Inhibitor Gilteritinib for Patients with FLT3 Mutations (AAML1831)
Hormone Studies
Hormone Study for Girls Ages 7 - 17
Study for the use of spironolactone to regulate menses in girls with excess male hormone
Leukemia
A Phase 3 Randomized Trial for Patients with de novo AML Comparing Standard Therapy Including Gemtuzumab Ozogamicin (GO) to CPX-351 with GO, and the Addition of the FLT3 Inhibitor Gilteritinib for Patients with FLT3 Mutations (AAML1831)
Pancreatic Disorders
Type 2 Diabetes and Dexcom G6 Continuous Glucose Monitor Research Study
Polycystic Ovarian Syndrome
Hormone Study for Girls Ages 7 - 17
Study for the use of spironolactone to regulate menses in girls with excess male hormone